Edwards Lifesciences's total assets for Q4 2024 were $13.06B, an increase of 0.65% from the previous quarter. EW total liabilities were $2.99B for the fiscal quarter, a -10.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.